Studies / Clinical Trials -  phase II IMC-A12 for sts (20 views) Notify me whenever anyone posts in this discussion.Subscribe
 
From: Swampwitch / laura (verlughmina) DelphiPlus Member Icon Posted by host9/9/08 2:28 PM 
To: All  (1 of 1) 
 566.1 

Phase 2 Study of IMC-A12 for Advanced Soft Tissue Sarcoma Opens for Patient Enrollment
From Business Wire NewsExpress - Jul 07, 2008
NEW YORK--(BUSINESS WIRE)--Jul 7, 2008 - ImClone Systems Incorporated, a global leader in the development and commercialization of novel antibodies to treat cancer, today announced that a Phase 2 clinical trial of IMC-A12, ImClone's fully human, IgG1 anti-insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody, in adolescents and adult patients with several types of soft tissue sarcoma has opened for patient enrollment.

to read whole article:

http://emailactivity.ecn5.com/engines/linkfrom.aspx?b=122896&e=27518159&l=http://www.therapeuticsdaily.com/news/article.cfm?contentvalue=554100&contenttype=newsarchive&channelID=28

to read summary:

http://emailactivity.ecn5.com/engines/linkfrom.aspx?b=122896&e=27518159&l=http://www.therapeuticsdaily.com/news/summary.cfm?id=554100&channelID=28

 
 Reply   Options 

First Discussion>>

 
Adjust text size:
Using a mobile device? Switch to the Mobile Site.

Welcome, guest! Get more out of Delphi Forums by logging in.

New to Delphi Forums? You can log in with your Facebook, Twitter, or Google account or use the New Member Login option and log in with any email address.

Home | Help | Forums | Chat | Blogs | Advertising | Membership Plans
© Delphi Forums LLC All rights reserved. Privacy Policy. Terms of Service.